- Home
- MPW vs PBH Comparison
MPW vs PBH Comparison
Compare MPW & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MPW | PBH |
|---|---|---|
| Founded | 2003 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.9B |
| IPO Year | 2005 | 2005 |
Fundamental Metrics
Financial Performance| Metric | MPW | PBH |
|---|---|---|
| Price | $5.05 | $63.92 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $5.88 | ★ $86.40 |
| AVG Volume (30 Days) | ★ 6.5M | 347.1K |
| Earning Date | 02-26-2026 | 02-05-2026 |
| Dividend Yield | ★ 6.54% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.04 |
| Revenue | $1,009,160,000.00 | ★ $1,110,479,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.27 | $2.50 |
| P/E Ratio | ★ N/A | $15.81 |
| Revenue Growth | ★ 52.52 | N/A |
| 52 Week Low | $3.95 | $57.25 |
| 52 Week High | $6.34 | $90.04 |
Technical Indicators
Market Signals| Indicator | MPW | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 49.76 |
| Support Level | $5.02 | $63.97 |
| Resistance Level | $5.16 | $68.28 |
| Average True Range (ATR) | 0.15 | 1.71 |
| MACD | -0.02 | -0.29 |
| Stochastic Oscillator | 20.34 | 20.72 |
Price Performance
Historical ComparisonAbout MPW Medical Properties Trust Inc. common stock
Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. The group's geographic areas are the United States, the United Kingdom, and All other countries.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.